204
Views
21
CrossRef citations to date
0
Altmetric
ORGINAL ARTICLES

Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis

, , , , , , & show all
Pages 24-29 | Received 30 Oct 2006, Published online: 08 Jul 2009

References

  • MacGowan AP. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother 2003; 51: 17–25
  • Stalker DJ, Jungbluth GL. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet 2003; 42: 1129–40
  • Joukhadar C, Derendorf H, Muller M. Microdialysis. A novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol 2001; 57: 211–9
  • Stolle LB, Arpi M, Holmberg-Jorgensen P, Riegels-Nielsen P, Keller J. Application of microdialysis to cancellous bone tissue for measurement of gentamicin levels. J Antimicrob Chemother 2004; 54: 263–5
  • Muller M. Science, medicine, and the future: microdialysis. Br Med J 2002; 324: 588–91
  • Stolle LB, Arpi M, Jorgensen PH, Riegels-Nielsen P, Keller J. In situ gentamicin concentrations in cortical bone: an experimental study using microdialysis in bone. Acta Orthop Scand 2003; 74: 611–6
  • Buerger C, Joukhadar C, Muller M, Kloft C. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 796: 155–64
  • Lovering AM, Zhang J, Bannister GC, Lankester BJ, Brown JH, Narendra G, et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 2002; 50: 73–7
  • Bellmann R, Kuchling G, Dehghanyar P, Zeitlinger M, Minar E, Mayer BX, et al. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br J Clin Pharmacol 2004; 57: 563–8
  • Muller M, Brunner M, Hollenstein U, Joukhadar C, Schmid R, Minar E, et al. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother 1999; 43: 2056–8
  • Buerger C, Plock N, Dehghanyar P, Joukhadar C, Kloft C. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis. Antimicrob Agents Chemother 2006; 50: 2455–63
  • Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 2001; 29: 385–91
  • Stolle, LB, Plock, N, Joukhadar, C, Arpi, M, Emmertsen, KJ, Buerger, C, , et al. Microdialysis in bone tissue: pharmacokinetics of Linezolid 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, D.C., 2005.
  • Thorsen K, Kristoffersson AO, Lerner UH, Lorentzon RP. In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest 1996; 98: 2446–9
  • Heinze, A, Holzgrabe, U. Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method. Int J Pharm 2006;311: 108–112, Epub 2006: Jan 2020.
  • Ford CW, Zurenko GE, Barbachyn MR. The discovery of linezolid, the first oxazolidinone antibacterial agent. Curr Drug Targets Infect Disord 2001; 1: 181–99
  • Kutscha-Lissberg F, Hebler U, Muhr G, Koller M. Linezolid penetration into bone and joint tissues infected with methicillin resistant staphylococci. Antimicrob Agents Chemother 2003; 47: 3964–6
  • Perry CM, Jarvis B. Linezolid: a review of its use in the management of serious Gram-positive infections. Drugs 2001; 61: 525–51
  • Rao N, Ziran BH, Hall RA, Santa ER. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004; 427: 67–71
  • Rayner CR, Baddour LM, Birmingham MC, Norden C, Meagher AK, Schentag JJ. Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 2004; 32: 8–14
  • EUCAST. Oxazolidinones: EUCAST clinical MIC breakpoints, http://www.srga.org/eucastwt/MICTAB/index.html, 2004.
  • Forrest, A. Patient studies modelling surrogates and their linkages: MIC, clinical scoring and PK/PD indices of effect: 15th ISAP International Symposium 2005. Washington, DC.
  • Mouton, JW. Pharmacodynamic Indices: 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005. Washington, DC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.